Payment overview · 2025
General Payments
$91.35
5 reported records · 3 companies
Healthcare provider profile · identity verified
Stanley John Mathew, M.D.
Allopathic & Osteopathic Physicians|Physical Medicine & Rehabilitation · CEDAR RAPIDS, IA · NPI 1003053653
Verified facts
What the public records show
CMS Open Payments records show Stanley John Mathew, M.D. received $91.35 in general payments during 2025 across 5 reported records.
PFIZER INC. accounted for 38.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Nurtec Odt.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Creon by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LUMIGAN as an associated drug or biological on 25016 records involving 7645 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Lumigan by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported VRAYLAR as an associated drug or biological on 377741 records involving 62704 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Vraylar by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 1193 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NURTEC ODT as an associated drug or biological on 217574 records involving 54025 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Nurtec Odt by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| PFIZER INC. | Unresolved — no canonical attribution shown | $35.30 | 38.6% | 2 | 2025 |
| VERTEX PHARMACEUTICALS INCORPORATED | Unresolved — no canonical attribution shown | $33.14 | 36.3% | 2 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $22.91 | 25.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $91.35 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $35.30 | 2 | 2025 |
Source payment records
|
|||||
| ZAVZPRET Normalized: zavzpret |
Drug | PFIZER INC. | $35.30 | 2 | 2025 |
Source payment records
|
|||||
| JOURNAVX Normalized: journavx |
Drug | VERTEX PHARMACEUTICALS INCORPORATED | $33.14 | 2 | 2025 |
Source payment records
|
|||||
| BOTOX Normalized: botox |
Biological | ABBVIE INC. | $22.91 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| NURTEC ODT nurtec odt |
2025 | Nurtec Odt | 2024 | 17 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | CREON open payments reported associated product |
CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608 |
Creon · 2024 Exact normalized brand match · 1 Part D row |
17 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
15 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LUMIGAN open payments reported associated product |
CMS Open Payments — General Payments 25016 supporting records · 7645 recipient NPIs · example record 1201352548 |
Lumigan · 2024 Exact normalized brand match · 1 Part D row |
13 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | VRAYLAR open payments reported associated product |
CMS Open Payments — General Payments 377741 supporting records · 62704 recipient NPIs · example record 1201352550 |
Vraylar · 2024 Exact normalized brand match · 1 Part D row |
12 | suppressed by CMS |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
1193 | 132 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | NURTEC ODT open payments reported associated product |
CMS Open Payments — General Payments 217574 supporting records · 54025 recipient NPIs · example record 1228794063 |
Nurtec Odt · 2024 Exact normalized brand match · 1 Part D row |
17 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1470 | 267 |
| Eliquis | Apixaban | 1193 | 132 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1127 | 175 |
| Furosemide | Furosemide | 1056 | 199 |
| Gabapentin | Gabapentin | 1049 | 221 |
| Amlodipine Besylate | Amlodipine Besylate | 940 | 156 |
| Potassium Chloride | Potassium Chloride | 928 | 156 |
| Lisinopril | Lisinopril | 898 | 145 |
| Pantoprazole Sodium | Pantoprazole Sodium | 776 | 151 |
| Tamsulosin Hcl | Tamsulosin Hcl | 767 | 145 |
| Trazodone Hcl | Trazodone Hcl | 734 | 154 |
| Sertraline Hcl | Sertraline Hcl | 717 | 105 |
| Metoprolol Tartrate | Metoprolol Tartrate | 606 | 103 |
| Metoprolol Succinate | Metoprolol Succinate | 596 | 106 |
| Metformin Hcl | Metformin Hcl | 507 | 89 |
| Escitalopram Oxalate | Escitalopram Oxalate | 490 | 79 |
| Duloxetine Hcl | Duloxetine Hcl | 431 | 95 |
| Baclofen | Baclofen | 418 | 79 |
| Levetiracetam | Levetiracetam | 411 | 73 |
| Clopidogrel | Clopidogrel Bisulfate | 407 | 74 |
| Donepezil Hcl | Donepezil Hcl | 395 | 62 |
| Losartan Potassium | Losartan Potassium | 386 | 76 |
| Famotidine | Famotidine | 359 | 53 |
| Omeprazole | Omeprazole | 350 | 71 |
| Mirtazapine | Mirtazapine | 349 | 76 |
| Quetiapine Fumarate | Quetiapine Fumarate | 331 | 82 |
| Simvastatin | Simvastatin | 318 | 42 |
| Prednisone | Prednisone | 292 | 126 |
| Buspirone Hcl | Buspirone Hcl | 290 | 57 |
| Xarelto | Rivaroxaban | 284 | 23 |
| Divalproex Sodium | Divalproex Sodium | 282 | 48 |
| Finasteride | Finasteride | 279 | 57 |
| Memantine Hcl | Memantine Hcl | 278 | 38 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 275 | 77 |
| Montelukast Sodium | Montelukast Sodium | 269 | 33 |
| Carvedilol | Carvedilol | 259 | 65 |
| Jardiance | Empagliflozin | 255 | 28 |
| Tizanidine Hcl | Tizanidine Hcl | 250 | 71 |
| Risperidone | Risperidone | 238 | 37 |
| Fluoxetine Hcl | Fluoxetine Hcl | 237 | 38 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 224 | 30 |
| Myrbetriq | Mirabegron | 216 | 17 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 215 | 40 |
| Lorazepam | Lorazepam | 211 | 76 |
| Pregabalin | Pregabalin | 200 | 45 |
| Aripiprazole | Aripiprazole | 196 | 32 |
| Ropinirole Hcl | Ropinirole Hcl | 195 | 31 |
| Bumetanide | Bumetanide | 193 | 34 |
| Olanzapine | Olanzapine | 192 | 32 |
| Spironolactone | Spironolactone | 191 | 35 |
| Midodrine Hcl | Midodrine Hcl | 190 | 50 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 186 | 36 |
| Warfarin Sodium | Warfarin Sodium | 183 | 26 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 182 | 37 |
| Topiramate | Topiramate | 181 | 33 |
| Cephalexin | Cephalexin | 177 | 98 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 171 | 33 |
| Fluticasone Propionate | Fluticasone Propionate | 168 | 50 |
| Tramadol Hcl | Tramadol Hcl | 166 | 73 |
| Hydrochlorothiazide | Hydrochlorothiazide | 163 | 33 |
| Methocarbamol | Methocarbamol | 162 | 83 |
| Ondansetron Hcl | Ondansetron Hcl | 145 | 53 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 145 | 18 |
| Alendronate Sodium | Alendronate Sodium | 142 | 20 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 140 | 81 |
| Azithromycin | Azithromycin | 133 | 66 |
| Citalopram Hbr | Citalopram Hydrobromide | 132 | 21 |
| Latanoprost | Latanoprost | 131 | 28 |
| Pravastatin Sodium | Pravastatin Sodium | 130 | 21 |
| Bupropion Xl | Bupropion Hcl | 128 | 30 |
| Benztropine Mesylate | Benztropine Mesylate | 125 | 21 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 123 | 27 |
| Trulicity | Dulaglutide | 123 | 13 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 121 | 49 |
| Haloperidol | Haloperidol | 119 | 19 |
| Lamotrigine | Lamotrigine | 118 | 17 |
| Clonazepam | Clonazepam | 112 | 18 |
| Oxybutynin Chloride | Oxybutynin Chloride | 112 | 25 |
| Metformin Hcl Er | Metformin Hcl | 107 | 26 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 106 | 43 |
| Acetic Acid | Acetic Acid | 103 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 100 | 26 |
| Celecoxib | Celecoxib | 98 | 30 |
| Oxycodone Hcl | Oxycodone Hcl | 91 | 27 |
| Allopurinol | Allopurinol | 90 | 23 |
| Methylprednisolone | Methylprednisolone | 89 | 71 |
| Humalog | Insulin Lispro | 88 | 15 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 85 | 15 |
| Levofloxacin | Levofloxacin | 84 | 47 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 83 | 18 |
| Amiodarone Hcl | Amiodarone Hcl | 82 | 18 |
| Humalog Kwikpen U-100 | Insulin Lispro | 82 | 23 |
| Divalproex Sodium Er | Divalproex Sodium | 80 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 80 | 33 |
| Ketoconazole | Ketoconazole | 78 | 29 |
| Carbamazepine | Carbamazepine | 77 | suppressed |
| Scopolamine | Scopolamine | 77 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 75 | 35 |
| Incruse Ellipta | Umeclidinium Bromide | 75 | 16 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 75 | 49 |
| Metoclopramide Hcl | Metoclopramide Hcl | 73 | 17 |
| Amantadine | Amantadine Hcl | 71 | suppressed |
| Atenolol | Atenolol | 70 | 17 |
| Tresiba Flextouch U-100 | Insulin Degludec | 70 | 13 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 69 | 43 |
| Amitriptyline Hcl | Amitriptyline Hcl | 69 | 12 |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 69 | suppressed |
| Glipizide | Glipizide | 69 | 17 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 69 | 15 |
| Ibuprofen | Ibuprofen | 68 | 23 |
| Lyumjev Kwikpen U-100 | Insulin Lispro-Aabc | 68 | suppressed |
| Sulfasalazine | Sulfasalazine | 67 | suppressed |
| Tradjenta | Linagliptin | 67 | suppressed |
| Glimepiride | Glimepiride | 66 | 12 |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 65 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 64 | 63 |
| Propranolol Hcl | Propranolol Hcl | 64 | 13 |
| Digoxin | Digoxin | 63 | 12 |
| Ezetimibe | Ezetimibe | 62 | 12 |
| Diclofenac Sodium | Diclofenac Sodium | 61 | 29 |
| Meloxicam | Meloxicam | 61 | 15 |
| Venlafaxine Hcl | Venlafaxine Hcl | 61 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 60 | 39 |
| Clonidine Hcl | Clonidine Hcl | 60 | suppressed |
| Entresto | Sacubitril/Valsartan | 60 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 59 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 58 | suppressed |
| Chlorthalidone | Chlorthalidone | 57 | suppressed |
| Briviact | Brivaracetam | 56 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 56 | 19 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 56 | 22 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 55 | 15 |
| Albuterol Sulfate | Albuterol Sulfate | 54 | 32 |
| Breo Ellipta | Fluticasone/Vilanterol | 54 | suppressed |
| Calcium Acetate | Calcium Acetate | 54 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 51 | 36 |
| Sucralfate | Sucralfate | 51 | 16 |
| Torsemide | Torsemide | 50 | 17 |
| Clozapine | Clozapine | 49 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 49 | 35 |
| Metolazone | Metolazone | 46 | suppressed |
| Nifedipine Er | Nifedipine | 45 | suppressed |
| Tresiba | Insulin Degludec | 45 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 44 | 15 |
| Nortriptyline Hcl | Nortriptyline Hcl | 44 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 43 | 26 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 42 | suppressed |
| Levemir | Insulin Detemir | 41 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 41 | 12 |
| Brilinta | Ticagrelor | 40 | suppressed |
| Lacosamide | Lacosamide | 40 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 40 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 39 | 15 |
| Oxcarbazepine | Oxcarbazepine | 39 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 37 | suppressed |
| Enulose | Lactulose | 37 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 37 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 37 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 37 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 37 | 15 |
| Brimonidine Tartrate | Brimonidine Tartrate | 36 | suppressed |
| Hydrocortisone | Hydrocortisone | 36 | 12 |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 35 | suppressed |
| Amoxicillin | Amoxicillin | 34 | 23 |
| Diazepam | Diazepam | 34 | suppressed |
| Glipizide Er | Glipizide | 34 | suppressed |
| Nystatin | Nystatin | 34 | 26 |
| Alprazolam | Alprazolam | 33 | 12 |
| Fiasp | Insulin Aspart (Niacinamide) | 33 | suppressed |
| Naproxen | Naproxen | 33 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 32 | suppressed |
| Gemtesa | Vibegron | 32 | suppressed |
| Levemir Flexpen | Insulin Detemir | 32 | 16 |
| Nitroglycerin | Nitroglycerin | 32 | 25 |
| Novolog Flexpen | Insulin Aspart | 32 | 12 |
| Ipratropium Bromide | Ipratropium Bromide | 31 | suppressed |
| Ondansetron Odt | Ondansetron | 31 | 25 |
| Primidone | Primidone | 30 | suppressed |
| Amiloride Hcl | Amiloride Hcl | 29 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 29 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 29 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 29 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 29 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 29 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 29 | suppressed |
| Methotrexate | Methotrexate Sodium | 29 | suppressed |
| Phenytoin | Phenytoin | 29 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 28 | 19 |
| Lactulose | Lactulose | 28 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 28 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 27 | suppressed |
| Mupirocin | Mupirocin | 27 | 21 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 27 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 27 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 27 | suppressed |
| Ramelteon | Ramelteon | 27 | suppressed |
| Roflumilast | Roflumilast | 27 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 26 | 12 |
| Fenofibrate | Fenofibrate,micronized | 26 | suppressed |
| Haloperidol Lactate | Haloperidol Lactate | 26 | 15 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 26 | suppressed |
| Sulfasalazine Dr | Sulfasalazine | 26 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 25 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 25 | suppressed |
| Nystop | Nystatin | 25 | 19 |
| Orphenadrine Citrate Er | Orphenadrine Citrate | 25 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 25 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 25 | suppressed |
| Timolol Maleate | Timolol Maleate | 25 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 24 | suppressed |
| Norethindrone | Norethindrone | 24 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 24 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 23 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 23 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 23 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 23 | 19 |
| Meclizine Hcl | Meclizine Hcl | 23 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 23 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 23 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 23 | suppressed |
| Cefdinir | Cefdinir | 22 | 13 |
| Enoxaparin Sodium | Enoxaparin Sodium | 22 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 22 | suppressed |
| Zonisamide | Zonisamide | 22 | suppressed |
| Budesonide | Budesonide | 21 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 21 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 21 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 21 | suppressed |
| Dimethyl Fumarate | Dimethyl Fumarate | 20 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 20 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 20 | suppressed |
| Ozempic | Semaglutide | 20 | suppressed |
| Anastrozole | Anastrozole | 19 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 19 | 12 |
| Carbamazepine Er | Carbamazepine | 19 | suppressed |
| Humulin R U-500 Kwikpen | Insulin Regular, Human | 19 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 19 | suppressed |
| Nyamyc | Nystatin | 19 | 13 |
| Leflunomide | Leflunomide | 18 | suppressed |
| Lorazepam Intensol | Lorazepam | 18 | 16 |
| Lurasidone Hcl | Lurasidone Hcl | 18 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 18 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 18 | suppressed |
| Telmisartan | Telmisartan | 18 | suppressed |
| Asenapine Maleate | Asenapine Maleate | 17 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 17 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 17 | suppressed |
| Clonidine | Clonidine | 17 | suppressed |
| Creon | Lipase/Protease/Amylase | 17 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 17 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 17 | suppressed |
| Insulin Lispro | Insulin Lispro | 17 | suppressed |
| Januvia | Sitagliptin Phosphate | 17 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 17 | suppressed |
| Mirabegron Er | Mirabegron | 17 | suppressed |
| Movantik | Naloxegol Oxalate | 17 | suppressed |
| Nurtec Odt | Rimegepant Sulfate | 17 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Irbesartan | Irbesartan | 16 | suppressed |
| Lansoprazole | Lansoprazole | 16 | suppressed |
| Methimazole | Methimazole | 16 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 16 | 12 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 16 | 16 |
| Verapamil Er | Verapamil Hcl | 16 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 16 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 15 | suppressed |
| Dexamethasone | Dexamethasone | 15 | suppressed |
| Ertapenem | Ertapenem Sodium | 15 | suppressed |
| Fluconazole | Fluconazole | 15 | 14 |
| Linezolid | Linezolid | 15 | suppressed |
| Linzess | Linaclotide | 15 | suppressed |
| Travoprost | Travoprost | 15 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 15 | suppressed |
| Admelog | Insulin Lispro | 14 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 14 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 14 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 14 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 14 | suppressed |
| Fenofibrate | Fenofibrate | 14 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 14 | suppressed |
| Insulin Aspart | Insulin Aspart | 14 | suppressed |
| Nabumetone | Nabumetone | 14 | suppressed |
| Nadolol | Nadolol | 14 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 14 | suppressed |
| Savella | Milnacipran Hcl | 14 | suppressed |
| Xtampza Er | Oxycodone Myristate | 14 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 14 | suppressed |
| Bicalutamide | Bicalutamide | 13 | suppressed |
| Calcitriol | Calcitriol | 13 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 13 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 13 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 13 | suppressed |
| Folic Acid | Folic Acid | 13 | suppressed |
| Lumigan | Bimatoprost | 13 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 13 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 13 | suppressed |
| Sevelamer Hcl | Sevelamer Hcl | 13 | suppressed |
| Sodium Chloride | Sodium Chloride Irrig Solution | 13 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 13 | suppressed |
| Abiraterone Acetate | Abiraterone Acetate | 12 | suppressed |
| Acitretin | Acitretin | 12 | suppressed |
| Bromocriptine Mesylate | Bromocriptine Mesylate | 12 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 12 | suppressed |
| Cimetidine | Cimetidine | 12 | suppressed |
| Erythromycin | Erythromycin Base | 12 | suppressed |
| Fentanyl | Fentanyl | 12 | suppressed |
| Humulin R | Insulin Regular, Human | 12 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 12 | suppressed |
| Lovastatin | Lovastatin | 12 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 12 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 12 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 12 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 12 | suppressed |
| Ssd | Silver Sulfadiazine | 12 | suppressed |
| Vraylar | Cariprazine Hcl | 12 | suppressed |
| Alogliptin | Alogliptin Benzoate | 11 | suppressed |
| Clotrimazole | Clotrimazole | 11 | suppressed |
| Daptomycin | Daptomycin | 11 | suppressed |
| Formoterol Fumarate | Formoterol Fumarate | 11 | suppressed |
| Glucagon Emergency Kit | Glucagon | 11 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 11 | suppressed |
| Loperamide | Loperamide Hcl | 11 | suppressed |
| Ranolazine Er | Ranolazine | 11 | suppressed |
| Tiotropium Bromide | Tiotropium Bromide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $91.35 · 5 records | PFIZER INC. | BOTOX, JOURNAVX, NURTEC ODT, ZAVZPRET | 6 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Nurtec Odt play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error